The Establishment of Dendritic Cell-Tumor Fusion Vaccines for Hormone Refractory Prostate Cancer Cell

PURPOSE: Dendritic cell (DC)-based tumor vaccine is an attractive modality for the treatment of hormone-refractory prostate cancer (HRPC) because it has some efficacy and few side effects in patients with poor general conditions. The aim of this study was to establish which is the most effective DC...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Kim, Tae-Beom, Park, Ho Ki, Chang, Joo Hyun, Choi, In Ho, Kim, Khae Hawn, Yoon, Sang Jin, Lee, Min Sung, Jung, Han, Kim, Choung-Soo
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: The Korean Urological Association 2010
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2855480/
https://ncbi.nlm.nih.gov/pubmed/20414428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4111/kju.2010.51.2.139
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg